JS. Wang, W. Wang; HG. Xie; SL. Huang; HH. Zhou, Effect of troleandomycin on the pharmacokinetics of imipramine in Chinese: the role of CYP3A., in Br J Clin Pharmacol, vol. 44, n. 2, Ago 1997, pp. 195-8, PMID 9278210.
H. Yamazaki, T. Shimada, Comparative studies of in vitro inhibition of cytochrome P450 3A4-dependent testosterone 6beta-hydroxylation by roxithromycin and its metabolites, troleandomycin, and erythromycin., in Drug Metab Dispos, vol. 26, n. 11, Nov 1998, pp. 1053-7, PMID 9806945.
E. Genazzani, The pharmacological and pharmacokinetic properties of troleandomycin, in Quad Antibiot, Giu 1975, pp. 35-56, PMID 210708.
A. Siracusa, G. Brugnami; T. Fiordi; S. Areni; C. Severini; A. Marabini, Troleandomycin in the treatment of difficult asthma., in J Allergy Clin Immunol, vol. 92, n. 5, Nov 1993, pp. 677-82, PMID 8227858.
TR. Flotte, GM. Loughlin, Benefits and complications of troleandomycin (TAO) in young children with steroid-dependent asthma., in Pediatr Pulmonol, vol. 10, n. 3, 1991, pp. 178-82, PMID 1852515.
B. Uzzan, R. Vassy; P. Nicolas; A. Chapman; G. Perret, Troleandomycin hepatotoxicity: a case report of overt jaundice and a placebo-controlled trial., in Therapie, vol. 48, n. 1, pp. 61-2, PMID 8356550.
D. Larrey, G. Amouyal; G. Danan; C. Degott; D. Pessayre; JP. Benhamou, Prolonged cholestasis after troleandomycin-induced acute hepatitis., in J Hepatol, vol. 4, n. 3, Giu 1987, pp. 327-9, PMID 3496378.
JF. Givaudan, T. Gamby; Y. Privat, [Cholestatic jaundice following rifampicin-troleandomycin: one new case]., in Nouv Presse Med, vol. 8, n. 28, Giu 1979, p. 2357, PMID 315057.
SJ. Szefler, M. Brenner; WJ. Jusko; SL. Spector; KA. Flesher; EF. Ellis, Dose- and time-related effect of troleandomycin on methylprednisolone elimination., in Clin Pharmacol Ther, vol. 32, n. 2, Ago 1982, pp. 166-71, PMID 6980076.
SJ. Szefler, JQ. Rose; EF. Ellis; SL. Spector; AW. Green; WJ. Jusko, The effect of troleandomycin on methylprednisolone elimination., in J Allergy Clin Immunol, vol. 66, n. 6, Dic 1980, pp. 447-51, PMID 6968763.
AK. Kamada, MR. Hill; AM. Brenner; SJ. Szefler, Effect of low-dose troleandomycin on theophylline clearance: implications for therapeutic drug monitoring., in Pharmacotherapy, vol. 12, n. 2, 1992, pp. 98-102, PMID 1570234.
M. Weinberger, D. Hudgel; S. Spector; C. Chidsey, Inhibition of theophylline clearance by troleandomycin, in J Allergy Clin Immunol, vol. 59, n. 3, Mar 1977, pp. 228-31, PMID 300083.
TC. Hemsworth, KW. Renton, Depression of theophylline metabolism and elimination by troleandomycin and erythromycin., in Biochem Pharmacol, vol. 30, n. 11, Giu 1981, pp. 1299-304, PMID 6973975.
A. Franco, P. Bourlard; C. Massot; J. Lecoeur; H. Guidicelli; G. Bessard, [Acute ergotism caused by dihydroergotamine-triacetyloleandomycin association], in Nouv Presse Med, vol. 7, n. 3, Gen 1978, p. 205, PMID 307229.
C. Dravet, E. Mesdjian; B. Cenraud; J. Roger, Interaction between carbamazepine and triacetyloleandomycin., in Lancet, vol. 1, n. 8015, Apr 1977, pp. 810-1, PMID 66614.
E. Mesdjian, C. Dravet; B. Cenraud; J. Roger, Carbamazepine intoxication due to triacetyloleandomycin administration in epileptic patients, in Epilepsia, vol. 21, n. 5, Ott 1980, pp. 489-96, PMID 6968264.
AM. Baciewicz, Carbamazepine drug interactions, in Ther Drug Monit, vol. 8, n. 3, 1986, pp. 305-17, PMID 3092407.
P. Fournier, G. Pacouret; B. Charbonnier, [A new cause of torsades de pointes: combination of terfenadine and troleandomycin]., in Ann Cardiol Angeiol (Paris), vol. 42, n. 5, Mag 1993, pp. 249-52, PMID 8368797.